NRP vs DHOPE vs COR-NMP in ECD-DCD Donation
NCT05327478 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-04-14
Summary
There is still a discrepancy between the number of liver transplant candidates and the availability of liver grafts, resulting in waiting list mortality. To increase the supply of suitable liver grafts, extended-donor criteria allografts can be used. However, in the case of donation after cardiac death this is not without a risk. Donor after cardiac death (DCD) grafts have increased risk of primary non function and biliary complications, resulting in either retransplantation, patient morbidity or patient death. Due to uncertainty of their quality DCD grafts can be discarded. However, normothermic machine perfusion (NRP) has the potential to overcome these disadvantages of DCD liver grafts. In DCD livers the physiological abdominal circulation is simulated with in vivo, normothermic, oxygenated perfusion during the first two hours after cardiac death. With this perfusion technique, early ischemia can be reversed, surgical damage due to a hasty procedure can be prevented and organs can be tested on viability. In many countries, NRP is obligatory, however this is not the current golden standard in the Netherlands. The primary objective of this study is the utilization of livers after NRP. Secondary study parameters are reasons for graft discard or rejection at proposal, patient- and graft survival, biliary complications, cost assessment of NRP and outcomes of kidney and pancreas transplants. This multicenter, observational study will be performed on adult liver transplant recipients who have been allocated a DCD liver graft (Maastricht type III and V) of a donor above fifty years old. According to current national procurement protocol, grafts procured in region west will be retrieved with NRP followed by dual hypothermic oxygenated perfusion (DHOPE). Grafts retrieved in region East/North will be retrieved using standard rapid retrieval followed by DHOPE, if the donor is aged 50-60. Grafts from donors aged above 60 will undergo controlled oxygenated rewarming normothermic machine perfusion (COR-NMP) after DHOPE.
Conditions
- Liver Transplant
- Organ Perfusion
- Complication of Surgical Procedure
Interventions
- PROCEDURE
-
NRP
Normothermic Regional Perfusion
- PROCEDURE
-
DHOPE
Dual Hypothermic Oxygenated Perfusion
- PROCEDURE
-
COR-NMP
Controlled Oxygenated Rewarming Normothermic Machine Perfusion
Sponsors & Collaborators
-
University Medical Center Groningen
collaborator OTHER -
Leiden University Medical Center
collaborator OTHER - lead OTHER
Principal Investigators
-
Jeroen de Jonge, Dr. · Erasmus Medical Center
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2024-05-01
- Completion
- 2029-05-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Hypothermic Oxygenated Perfusion for Extended Criteria Donors in Liver Transplantation (HOPExt)
NCT03929523 ·Status: COMPLETED ·Phase: NA
-
Heart Transplantation Utilizing NRP DCD
NCT05243914 ·Status: TERMINATED
-
Long-term Outcomes After Prolonged Dual Hypothermic Oxygenated Machine Perfusion of Donor Livers (DHOPEPROLONG)
NCT05680246 ·Status: RECRUITING
-
Liver Graft Viability Assessment During Normothermic Regional Perfusion
NCT05361044 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.
NCT06740578 ·Status: COMPLETED
-
The Regenerative Capacity of the Donor Liver After Living Donor Liver Transplantation: an Ambidirectional Cohort Study
NCT07329296 ·Status: ENROLLING_BY_INVITATION
-
Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors
NCT03378817 ·Status: COMPLETED ·Phase: NA
-
Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy
NCT01197573 ·Status: COMPLETED ·Phase: NA
-
Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation
NCT05031052 ·Status: RECRUITING ·Phase: NA
-
Cardiovascular Evaluation Before Renal Transplantation
NCT01064674 ·Status: UNKNOWN
-
APCext : Effect of Temporary Porto-caval Shunt During Liver Transplantation on Function of Liver Graft From Extended Criteria Donor
NCT02784119 ·Status: RECRUITING ·Phase: NA
-
Renal Perfusion, Filtration and Oxygenation After Liver Transplantation -Effects of av Postoperative Blood Pressure
NCT02455115 ·Status: COMPLETED ·Phase: NA
-
Descemet Membrane Endothelial Keratoplasty (DMEK)
NCT00521898 ·Status: COMPLETED ·Phase: NA
-
Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers
NCT06950398 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Hypothermic Oxygenated Perfusion (HOPE) of Human Liver Grafts
NCT01317342 ·Status: COMPLETED ·Phase: NA
-
Assessing Declined Liver Grafts With Normothermic Machine Perfusion to Reduce Transplant Waiting Time
NCT06874296 ·Status: RECRUITING ·Phase: NA
-
Predictive Accuracy of Machine Perfusion for Kidney Transplant Outcomes in Germany
NCT07348874 ·Status: NOT_YET_RECRUITING
-
Home-Care Needs in Liver or Renal Transplantation Recipients and Their Spouses
NCT01380002 ·Status: UNKNOWN
-
Comparison of Robot-assisted Donornephrectomy vs Hand-assisted Laparoscopic Donornephrectomy
NCT05194280 ·Status: COMPLETED
-
The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft Function
NCT03107858 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation
NCT03946852 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Liver Transplantation and Coronavirus Disease 2019 (COVID-19)
NCT04695756 ·Status: UNKNOWN
-
Therapeutic Hypothermia in "Expanded Criteria" Brain-dead Donors and Kidney-graft Function
NCT03098706 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation
NCT04376775 ·Status: COMPLETED
-
Uncontrolled Donation After Circulatory Determination of Death (uDCDD)
NCT03935230 ·Status: COMPLETED